<bill session="116" type="s" number="3578" updated="2020-04-18T04:28:19Z">
  <state datetime="2020-03-24">REFERRED</state>
  <status>
    <introduced datetime="2020-03-24"/>
  </status>
  <introduced datetime="2020-03-24"/>
  <titles>
    <title type="short" as="introduced">COVID-19 Funding Accountability Act of 2020</title>
    <title type="short" as="introduced">COVID-19 Funding Accountability Act of 2020</title>
    <title type="display">COVID-19 Funding Accountability Act of 2020</title>
    <title type="official" as="introduced">A bill to provide oversight for the care and assistance provided to businesses under the coronavirus relief package.</title>
  </titles>
  <sponsor bioguide_id="G000386"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-03-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-03-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Homeland Security and Governmental Affairs.</text>
      <reference ref="CR S2009" label="Sponsor introductory remarks on measure"/>
      <reference ref="CR S2011-2013" label="text"/>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSGA" name="Senate Homeland Security and Governmental Affairs" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Government operations and politics"/>
    <term name="Accounting and auditing"/>
    <term name="Advisory bodies"/>
    <term name="Aviation and airports"/>
    <term name="Banking and financial institutions regulation"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Congressional agencies"/>
    <term name="Congressional operations and organization"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Criminal investigation, prosecution, interrogation"/>
    <term name="Economic performance and conditions"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Executive agency funding and structure"/>
    <term name="Financial crises and stabilization"/>
    <term name="Financial services and investments"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Government lending and loan guarantees"/>
    <term name="Government studies and investigations"/>
    <term name="Health programs administration and funding"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Marketing and advertising"/>
    <term name="Small business"/>
  </subjects>
  <amendments/>
  <summary date="2020-03-24T04:00:00Z" status="Introduced in Senate">COVID-19 Funding Accountability Act of 2020

This bill provides oversight for the use of assistance provided to businesses under COVID-19 (i.e., coronavirus disease 2019) relief programs.

The bill establishes a COVID-19 Relief Oversight Board.

The Office of Management and Budget&#160;shall issue regulations or guidelines necessary to address and manage or to prohibit conflicts of interest that may arise in connection with the administration and execution of the authorities provided under COVID-19 relief programs.

The bill sets limits on compensation and bonuses for senior executives of private entities receiving certain emergency financial assistance.

The Government Accountability Office shall commence ongoing oversight of the activities and performance of the programs and any agents of the executive branch invoking federal authority or rendering assistance to private entities in response to the COVID-19 outbreak.

The bill establishes (1) a special inspector general office for COVID-19 relief programs, and (2)&#160;the Congressional Oversight Panel in the legislative branch.</summary>
  <committee-reports/>
</bill>
